Non-genomic regulation of cardiac ion channels by sex hormones

Cardiovascular and Hematological Disorders - Drug Targets

Volumn 8, Issue 4, 2008, Pages 245-251

  Furukawa, Tetsushi ^a,b   Kurokawa, Junko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE   (Japan)

Author keywords

Caveolae; Lipid raft; Long QT syndrome; Nitric oxide; S nitrosylation; Torsades de pointes

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CALCIUM CHANNEL; CYCLIC AMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPIANDROSTERONE; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; ION CHANNEL; NITRIC OXIDE; POTASSIUM CHANNEL; PROGESTERONE RECEPTOR; SEX HORMONE; TESTOSTERONE;

ADRENERGIC SYSTEM; ARTICLE; CALCIUM CURRENT; CARDIOVASCULAR SYSTEM; CAVEOLA; ENZYME ACTIVATION; HEART MUSCLE CELL; HORMONAL REGULATION; HORMONE ACTION; HUMAN; LIPID RAFT; LONG QT SYNDROME; MEMBRANE CURRENT; NONHUMAN; POTASSIUM CURRENT; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; RISK FACTOR; SEX DIFFERENCE; SIGNAL TRANSDUCTION; TORSADE DES POINTES; ANIMAL; FEMALE; HEART; HEART ARRHYTHMIA; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SEXUAL DEVELOPMENT;

ANIMALS; ARRHYTHMIAS, CARDIAC; FEMALE; GONADAL STEROID HORMONES; HEART; HUMANS; ION CHANNELS; MALE; MYOCYTES, CARDIAC; NITRIC OXIDE; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION;

EID: 60549117507     PISSN: 1871529X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152908786786160     Document Type: Article

References (69)

1. Beato, M.; Klug, J. Steroid hormone receptors: An update. Hum. Reprod. Update, 2000, 6, 225-236.
2. Aranda, A.; Pascual, A. Nuclear hormone receptors and gene expression. Physiol. Rev., 2001, 81, 1269-1304.
3. McKenna, N.J.; O'Malley, B.W. Nuclear receptors, coregulators, ligands, and selective receptor modulators: making sense of the patchwork quilt. Ann. N. Y. Acand. Sci., 2001, 949, 3-5.
4. Selye, H. Correlations between the chemical structure and the pharmacological actions of the steroids. Endocrinology, 1942, 30, 437-452.
5. Stanten, R.; Jeng, M.H.; Wang, J.P.; Song, R.; Masamura, S.; McPherson, R.; Santner, S.; Yue, W.; Shim, W.S. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients. J. Steroid Biochem. Mol. Biol., 2001, 79, 115-125.
6. Lange, C.A.; Gioeli, D.; Hammes, S.R.; Marker, P.C. Integration of rapid signaling events with steroid hormone receptor action in breast and prostate cancer. Annu. Rev. Physiol., 2007, 69, 171-199.
7. Manolagas, S.C.; Kousteni, S.; Jilka, R.L. Sex steroids and bone. Recent Prog. Horm. Res., 2002, 57, 385-409.
8. McEwen, B.S.; Alves, S.E. Estrogen actions in the central nervous system. Endocr. Rev., 1999, 20, 279-307.
9. Marin, R.; Guerra, B.; Alonso, R.; Ramirez, C.M.; Diaz, M. Estrogen activates classical and alternative mechanisms to orchestrate neuroprotection. Curr. Neurovasc. Res., 2005, 2, 287-301.
10. Simoncini, T.; Mannella, P.; Fornari, L..; Caruso, A.; Varone, G.; Genazzani, A.R. Genomic and non-genomic effects of estrogens on endothelial cells. Steroids, 2004, 69, 537-542.
11. Hisamoto, K.; Bender, J.R. Vascular cell signaling by membrane estrogen receptors. Steroids, 2005, 70, 382-387.
12. Farhat, M.Y.; Chen, M.F.; Bhatti, T.; Iqbal, A.; Cathapermal, S.; Ramwell, P.W. Protection by oestraiol against the development of cardiovascular changes associated with monocrotaline pulmonary hypertension in rats. Br. J. Pharmacol., 1993, 110, 719-723.
13. McHugh, N.A.; Cook, S.M.; Schairer, J.L.; Bidgoli, M.M.; Merrill, G.F. Ischemia- and reperfusion-induced ventricular arrhythmias in dogs: effects of estrogen. Am. J. Physiol., 1995, 268, H2569-H2573.
14. Node, K.; Kitakaze, M.; Kosaka, H.; Minamino, T.; Funaya, H.; Hori, M. Amelioration of ischemia- and reperfusion-induced myocardial injury by 17beta-estradiol: role of nitric oxide and calcium-activateed potassium channels. Circulation, 1997, 96, 1953-1963.
15. Douglas, P.S.; Katz, S.E.; Weinberg, E.O.; Chen, M.H.; Bishop, S.P.; Lorell, B.H. Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J. Am. Coll. Cardiol., 1998, 32, 1118-1125.
16. Bai, C.X.; Kurokawa, J.; Tamagawa, M.; Nakaya, H.; Furukawa, T. Nontranscriptional regulation of cardiac repolarization currents by testosterone. Circulation, 2005, 112, 1701-1710.
17. Nakamura, H.; Kurokawa, J.; Bai, C.X.; Asada, K.; Xu, J.; Oren, R.V.; Zhu, Z.I.; Clancy, C.E.; Isobe, M.; Furukawa, T. Progesterone regulates cardiac repolarization through a nongenomic pathway: an in vitro patch-clamp and computational modeling study. Circulation, 2007, 116, 2913-2922.
18. Kr channels and drug-induced prolongation of cardiac repolarization. J. Physiol., 2008, 586, 2961-2973.
19. Berger, F.; Borchard, U.; Hafner, D.; Pütz, I.; Weis, T.M. Effects of 17beta-estradiol on action potentials and ionic currents in male rat ventricular myocytes. Naunyn. Schmiedebergs Arch. Pharmacol., 1997, 356, 788-796.
20. Nakajima, T.; Iwasawa, K.; Oonuma, H.; Morita, T.; Goto, A.; Wang, Y.; Hazama, H. Antiarrhythmic effect and its underlying ionic mechanism of 17beta-estradiol in cardiac myocytes. Br. J. Pharmacol., 1999, 127, 429-440.
21. Gupte, S.A.; Tateyama, M.; Okada, T.; Oka, M.; Ochi, R. Epiandrosterone, a metabolite of testosterone precursor, blocks L-type calcium channels of ventricular myocytes and inhibits myocardial contractility. J. Mol. Cell. Cardiol., 2002, 34, 679-688.
22. Tanabe, S.; Hata, T.; Hiraoka, M. Effects of estrogen on action potential and membrane currents in guinea pig ventricular myocytes. Am. J. Physiol., 1999, 277, H826-H833.
23. + current. Int. J. Andol., 2002, 25, 210-214.
24. Endoh, H.; Sasaki, H.; Maruyama, K.; Takeyama, K.; Waga, I.; Shimizu, T.; Kato, S.; Kawashima, H. Rapid activation of MAP kinase by estrogen in the bone cell line. Biochem. Biophys. Res. Commun., 1997, 235, 99-102.
25. Watters, J.J.; Campbell, J.S.; Cunningham, M.J.; Krebs, E.G.; Dorsa, S.M. Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signaling cascade and c-fos immediate early gene transcription. Endocrinology, 1997, 138, 4030-4033.
26. Simoncini, T.; Hafezi-Moghadam, A.; Brazil, D.P.; Ley, K.; Chin, W.W.; Liao, J.K. Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature, 2000, 407, 538-541.
27. Haynes, M.P.; Li, L.; Sinha, D.; Russel, K.S.; Hisamoto, K.; Baron, R.; Collinge, M.; Sessa, W.C.; Bender, J.R. Src kinase mediates phosphatidyl 3-kinase/Akt-dependent rapid endothelial nitric oxide synthase activation by estrogen. J. Biol. Chem., 2003, 278, 2118-2123.
28. 2+ current by ginsenoside Re, an ingredient of Panax ginseng, in guinea-pig cardiomyocytes. Br. J. Pharmacol., 2004, 142, 567-575.
29. Arnold, W.P.; Mittal, C.K.; Katsuki, S.; Murad, F. Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. USA, 1977, 74, 3203-3207.
30. Stamler, J.S.; Simon, D.I.; Osborne, J.A.; Mullins, M.E.; Jaraki, O.; Michel, T.; Singel, D.J.; Loscalzo, J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA, 1992, 89, 444-448.
31. Fischmeister, R.; Castro, L.; Abi-Gerges, A.; Rochais, F.; Vandecasteele, G. Species- and tissue-dependent effects of NO and cyclic GMP on cardiac ion channels. Comp. Biochem. Physiol. A Mol. Integr. Physiol., 2005, 142, 136-143.
32. Sun, J.; Morgan, M.; Shen, R.F.; Steenbergen, C.; Murphy, E. Preconditioning results in S-nitrosylation of proteins involved in regulation of mitochondrial energetics and calcium transport. Circ. Res., 2007, 101, 1155-1163.
33. Manolagas, S.C.; Kousteni, S. Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology, 2001, 142, 2200-2204.
34. 2+- independent nitric oxide synthase by 17beta-estradiol in postischemic rat heart. Cardiovasc. Res., 2000, 46, 111-118.
35. Wang, X.; Abdel-Rahman, A.A. Estrogen modulation of eNOS activity and its association with caveolin-3 and calmodulin in rat hearts. Am. J. Physiol., 2002, 282, H2309-H2315.
36. Dimmeler, S.; Fleming, I.; Fisslthaler, B.; Hermann, C.; Busse, R.; Zeiher, A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature, 1999, 399, 601-605.
37. Song, K.S.; Li, Shengwen.; Okamoto, T.; Quilliam, L.A.; Sargiacomo, M.; Lisanti, M.P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem., 1996, 271, 9690-9697.
38. Bain, D.L.; Heneghan, A.F.; Connaghan-Jones, K.D.; Miura, M.T. Nuclear receptor structure: Implications for function. Annu. Rev. Physiol., 2007, 69, 201-220.
39. Razandi, M.; Pedram, A.; Greene, G.L.; Levin, E.R. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol. Endocrinol., 1999, 13, 307-319.
40. Li, L.; Haynes, M.P.; Bender, J.R. Plasma membrane localization and function of the estrogen receptor alpha variant (ER46) in human endothelial cells. Proc. Natl. Acad. Sci. USA, 2003, 100, 4807-4812.
41. Toran-Allerand, C.D.; Guan, X.; MacLusky, N.J.; Horvath, T.L.; Diano, S.; Singh, M.; Connolly, E.S. Jr.; Nethrapalli, I.S.; Tinnikov, A.A. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J. Neurosci., 2002, 22, 8391-8401.
42. Catalano, M.G.; Comba, A.; Fazzari, A.; Benedusi-Pagliano, E.; Sberveglieri, M.; Revelli, A.; Massobrio, M.; Frairia, R.; Fortunati, N. Sex steroid binding protein receptor (SBP-R) is related to a reduced proliferation rate in human breast cancer. Breast Cancer Res. Treat., 1997, 42, 227-234.
43. Thomas, P.; Pang, Y.; Filardo, E.J.; Dong, J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrionology, 2005, 146, 624-632.
44. Nethrapalli, I.S.; Tinnikov, A.A.; Krishnan, V.; Lei, C.D.; Toran-Allerand, C.D. Estrogen activates mitogen-activated protein kinase in native, nontransfected CHO-K1, COS-7, and RAT2 fibroblast cell lines. Endocrinology, 2005, 146, 56-63.
45. Song, R.X.; Barnes, C.J.; Zhang, Z.; Bao, Y.; Kumar, R.; Santen, R.J. The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor alpha to the plasma membrane. Proc. Natl. Acad. Sci. USA, 2004, 101, 2076-2081.
46. Flouriot, G.; Brand, H.; Denger, S.; Metivier, R.; Kos, M.; Reid, G.; Sonntag-Buck, V.; Gannon, F. Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcript and that is able to repress hER-alpha activation function 1. EMBO J., 2000, 19, 4688-4700.
47. Denger, S.; Reid, G.; Kos, M.; Flouriot, G.; Parsch, D.; Brand, H.; Korach, K.S.; Sonntag-Buck, V.; Gannon, F. ERalpha gene expression in human primary osteoblasts: evidence for the expression of two receptor proteins. Mol. Endocrinol., 2001, 15, 2064-2077.
48. Russel, K.S.; Haynes, M.P.; Caulin-Glaser, T.; Rosneck, J.; Sessa, W.C.; Bender, J.R. Estrogen stimulates heat shock protein 90 binding proteins to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J. Biol. Chem., 2000, 275, 5026-5030.
49. Haynes, M.P.; Sinha, D.; Russel, K.S.; Collinge, M.; Fulton, D.; Morales-Ruiz, M.; Sessa, W.C.; Bender, J.R. Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ. Res., 2000, 87, 677-682.
50. Zhu, Y.; Rice, C.D.; Pang, Y.; Pace, M.; Thomas, P. Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes. Proc. Natl. Acad. Sci. USA, 2003, 100, 2231-2236.
51. Zhu, Y.; Bond, J.; Thomas, P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc. Natl. Acad. Sci. USA, 2003, 100, 2237-2242.
52. Falkenstein, E.; Meyer, C.; Eisen, C.; Scriba, P.C.; Wehling, M. Full-length cDNA sequence of a progesterone membrane-binding protein from porcine vascular smooth muscle cells. Biochem. Biophys. Res. Commun., 1996, 229, 86-89.
53. Selmin, O.; Lucier, G.W.; Clark, G.C.; Tritscher, A.M.; Vanden Heuvel, J.P.; Gastel, J.A.; Walker, N.J.; Sutter, T.R.; Bell, D.A. Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis, 1996, 17, 2609-2615.
54. Welter, B.H.; Hansen, E.L.; Saner, K.J.; Wei, Y.; Price, T.M. Membrane-bound progesterone receptor expression in human aortic endothelial cells. J. Histochem. Cytochem., 2003, 51, 1049-1055.
55. Bayaa, M.; Booth, R.A.; Sheng, Y.; Liu, X.J. The classical progesterone receptor mediates Xenopus oocyte maturation through a nongenomic mechanism. Proc. Natl. Acad. Sci. USA, 2000, 97, 12607-12612.
56. Selcer, K.W.; Smith, S.; Clemens, J.W.; Palmer, B.D. Androgen receptor in the oviduct of the turtle, Trachemys scripta. Comp. Biochem. Physiol. B Biochem. Mol. Biol., 2005, 141, 61-70.
57. Ahrens-Fath, I.; Politz, O.; Geserick, C.; Haendler, B. Androgen receptor function is modulated by the tissue-specific AR45 variant. FEBS J., 2005, 272, 74-84.
58. Hashiba, K. Hereditary QT prolongation syndrome in Japan: genetic analysis and pathological findings of the conducting system. Jpn. Circ. J., 1978, 42, 1133-1150.
59. Makkar, R.R.; Fromm, B.S.; Steinman, R.T.; Meissner, M.D.; Lehmann, M.H. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs. JAMA, 1993, 270, 2590-2597.
60. Priori, S.G.; Schwartz, P.J.; Napolitano, C.; Bloise, R.; Ronchetti, E.; Grillo, M.; Vicentini, A.; Spazzolini, C.; Nastoli, J.; Bottelli, G.; Folli, R.; Cappelletti, D. Risk stratification in the long-QT syndrome. N. Engl. J. Med., 2003, 348, 1866-1874.
61. Imboden, M.; Swan, H.; Denjoy, I.; Van Langen, I.M.; Latinen-Forsblom, P.J.; Napolitano, C.; Fressart, V.; Breithardt, G.; Berthet, M.; Priori, S.; Hainque, B.; Wilde, A.A.; Schulze-Bahr, E.; Feingold, J.; Guicheney, P. Female predominance and transmission distortion in the long-QT syndrome. N. Engl. J. Med., 2006, 355, 2744-2751.
62. Rauthaharju, P.M.; Zhou, S.H.; Wong, S.; Calhoun, H.P.; Berenson, G.S.; Prineas, R.; Davignon, A. Sex differences in the evolution of the electrocardiographic QT interval with age. Can. J. Cardiol., 1992, 8, 690-695.
63. Locati, E.H.; Zarba, W.; Moss, A.J.; Schwartz, P.J.; Vincent, G.M.; Lehmann, M.H.; Towbin, J.A.; Priori, S.G.; Napolitano, C.; Robinson, J.L.; Andrews, M., Timothy, K.; Hall, W.J. Age- and sex-related differences in clinical manifestations in patients with congenital long-QT syndrome: findings from the International LQTS Registry. Circulation, 1998, 97, 2237-2244.
64. Nakagawa, M.; Ooie, T.; Takahashi, N.; Taniguchi, Y.; Anan, F.; Yonemochi, H.; Saikawa, T. Influence of menstrual cycle on QT interval dynamics. Pacing Clin. Electrophyiol., 2006, 29, 607-613.
65. Rodoriguez, I.; Kilborn, M.J.; Liu, X.K.; Pezzullo, J.C.; Woosley, R.L. Drug-induced QT prolongation in women during the menstrual cycle. JAMA, 2001, 285, 1322-1326.
66. Rashba, E.J.; Zareba, W.; Moss, A.J.; Hall, W.J.; Robinson, J.; Locati, E.H.; Schwartz, P.J.; Andrews, M. Influence of pregnancy on the risk for cardiac events in patients with hereditary long QT syndrome. LQTS Investigators. Circulation, 1998, 97, 451-456.
67. Drici, M.D.; Burklow, T.R.; Haridasse, V.; Glazer, R.I.; Woosley, R.L. Sex hormones prolong the QT interval and downregulate potassium channel expression in the rabbit heart. Circulation, 1996, 94, 1471-1474.
68. Song, M.; Helguera, G.; Eghbali, M.; Zhu, N.; Zarei, M.M.; Olcese, R.; Toro, L.; Stefani, E. Remodeling of Kv4.3 potassium channel gene expression under the control of sex hormones. J. Biol. Chem., 2001, 276, 31883-31890.
69. Liu, X.K.; Katchman, A.; Whitfield, B.H.; Wan, G.; Janowski, E.M.; Woosley, R.L.; Ebert, S.N. In vivo androgen treatment shortens the QT interval and increases the densities of inward and delayed rectifier potassium currents in orchiectomized male rabbits. Cardiovasc. Res., 2003, 57, 28-36.